RT @Michael44364760: My article has been recommended on @F1000Prime https://t.co/5t39K9A2lh
My article has been recommended on @F1000Prime https://t.co/5t39K9A2lh
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @hus_qy: 3\ ... for curing cancer and human trials in terminally ill patients could start as early as this year. This is a really big b…
Novel/potentially universal cancer treatment, which happened to be stumbled upon. I particularly enjoyed figure 4 'does not recognise MR1 by known mechanisms'. Great way of saying We don't know, we tried to find out! 😅 (Great research from Cardiff!)🔬 htt
RT @TrentonBricken: Really exciting paper on a T-cell receptor that has the potential to recognize and kill many different cancers for almo…
Pretty exciting paper, describing a T cell receptor that seems to recognize a variety of cancer cell lines but does not kill healthy cells. https://t.co/Ni7xbdzIV0
Hope for preventing/treating and curing most cancers in my lifetime: https://t.co/RQTg7U0JcU
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
#ImmunologyDiscovery: #UbiquitousTCellsCancerTargetting: #Genomewide #CRISPRCas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. - PubMed - NCBI https://t.co/bqdnPgZX7s
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
New kind of MR1 restricted invariant T cells show potent cancer killing ability. Unlike mucosa associated invariant Tcells, MR1 recognition is decreased by Vitamin B metabolites Non-cancer cells have low MR1 surface expression without bacterial metaboltes
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
RT @danablankenhorn: @DavidCornDC @BettyBuckley Use first sources, Dave. https://t.co/FnqDZA7dZf
Could this attack Coronavirus? All of them?
@DavidCornDC @BettyBuckley Use first sources, Dave. https://t.co/FnqDZA7dZf
@KevinHague @DavidCornDC @MikeWesleySmith This link is in the article → https://t.co/WbYiejGcdO
This is a wonderful discovery, but I don't get why the press is characterizing it as an "accident". Exploratory research is designed to discover things we don't know & therefore can't predict. Seems very intentional to me. #discoverybasedscience https:
RT @deanbarker: The study itself. https://t.co/5sMhSOuXVX
RT @deanbarker: The study itself. https://t.co/5sMhSOuXVX
@DavidCornDC Full text, actual research, peer review reporting: https://t.co/uyvluWRCAd
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 | Nature Immunology https://t.co/iATAEaktPe
RT @Lizzy_Lang7: This paper is behind a pay wall, but if you can get access, take a read. It's really interesting. They might have found a…
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
Hopefully the cure is in sight 🥳🥳
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
"...suggesting that recognition occurred via sensing of the cancer metabolome." https://t.co/pM22ip4YWB
See paper here: https://t.co/nC5xUy49bp
Looks like we might be on to an actual cure to cancer!!! https://t.co/oKSzKWKgmO
T-cells that kill any type of cancer you throw at it. This could be as close as it gets to a "magic bullet" cancer cure! https://t.co/Dpi46kJVu2
RT @actuallyaswin: 2020 brings us closer towards a general-purpose cure for cancer! 🥳 Here’s a paper by researchers from Cardiff, UK showin…
RT @Lizzy_Lang7: This paper is behind a pay wall, but if you can get access, take a read. It's really interesting. They might have found a…
MR1-restricted T-cells might be the universal cure for cancers? More tests needed to confirm the mechanism and the possibility of treatment on patients. source: https://t.co/3nAyD5yLtg https://t.co/AWXdYXUL6w
Really exciting paper on a T-cell receptor that has the potential to recognize and kill many different cancers for almost everyone (it binds to MR1 which is a MHC Class 1 that is highly conserved) h/t @_nathanrollins https://t.co/2RPZ4uCE8s
RT @Lizzy_Lang7: This paper is behind a pay wall, but if you can get access, take a read. It's really interesting. They might have found a…
2020 brings us closer towards a general-purpose cure for cancer! 🥳 Here’s a paper by researchers from Cardiff, UK showing how a type of T-cell receptor was able to attack multiple varieties of human cancers through interactions with the MR1 protein. 🧬 🔬 ht
RT @Lizzy_Lang7: This paper is behind a pay wall, but if you can get access, take a read. It's really interesting. They might have found a…
RT @Lizzy_Lang7: This paper is behind a pay wall, but if you can get access, take a read. It's really interesting. They might have found a…
RT @Lizzy_Lang7: This paper is behind a pay wall, but if you can get access, take a read. It's really interesting. They might have found a…
RT @Lizzy_Lang7: This paper is behind a pay wall, but if you can get access, take a read. It's really interesting. They might have found a…
RT @Lizzy_Lang7: This paper is behind a pay wall, but if you can get access, take a read. It's really interesting. They might have found a…
This paper is behind a pay wall, but if you can get access, take a read. It's really interesting. They might have found a killer T cell that can detect and destroy all types of cancers. More research will be done soon and this is quite promising. https://
Very exciting new study from Wales https://t.co/2MvvDhw3nm
So this is pretty neat: In this paper they describe a TCR that has "pan-cancer recognition" by targeting an invariant form of MR1 that appears to be necessary for cancer cell survival and does not appear on the surface of healthy cells. https://t.co/Gctn7
RT @toxiven_biotech: For further information go to link: https://t.co/RR06exxvIT
RT @toxiven_biotech: For further information go to link: https://t.co/RR06exxvIT
RT @toxiven_biotech: For further information go to link: https://t.co/RR06exxvIT
RT @toxiven_biotech: For further information go to link: https://t.co/RR06exxvIT
Okay one of the most important discoveries in T cell biology might have just happened https://t.co/stxDKq2pij
Possible cure for cancer? https://t.co/paiFUYGr2B
now there's something worth keeping an eye on
MR1 recognition by T cells as promising new cancer immunotherapy. Link to original article https://t.co/QaMiMRXGlS
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
RT @StojdlLab: Genome-wide CRISPR-Cas9 screening finds a HLA-independent T cell receptor that targets #cancer vs. non-cancer cells via the…
RT @StojdlLab: Genome-wide CRISPR-Cas9 screening finds a HLA-independent T cell receptor that targets #cancer vs. non-cancer cells via the…
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 | Nature Immunology | https://t.co/7ByO7uuXKX
RT @NatImmunol: Sewell and colleagues show nonclassical MHC molecule MR1 is expressed on a wide variety of cancer types and can be targeted…
Genome-wide CRISPR-Cas9 screening finds a HLA-independent T cell receptor that targets #cancer vs. non-cancer cells via the MHC class I-related protein, MR1, based on sensing the cancer #metabolome: https://t.co/IN7DJPeUak via @NatImmunol @cardiffuni @UofU
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
Abierta la puerta para la vida. #másinvestigaciónparamásvida
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
RT @SEinmunologia: Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-an…
Describen un tipo de #célulaT HLA-independiente capaz de destruir únicamente células tumorales vía reconocimiento MR1-antígeno tumoral (desconocido). Abierta la puerta para la creación de células T universales para #inmunoterapiadelcancer #inmunopower. ➡️h
Genome-wide #CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. Crowther, M. D. et al. Nat. Immunol. 21, 178–185 (2020) https://t.co/9YzVffyGkO
RT @DrMinoshima: Discovery of ubiquitous T cell receptors that recognize multiple cancer cells without affecting normal cells, just publish…
RT @DrMinoshima: Discovery of ubiquitous T cell receptors that recognize multiple cancer cells without affecting normal cells, just publish…
@UofURadiology
Discovery of ubiquitous T cell receptors that recognize multiple cancer cells without affecting normal cells, just published in Nat Immunol. Exciting intercontinental collaboration by John Phillips @UofUHealth @UUtah. Hope for cancer cure https://t.co/
Check out this brand new Nature article on a new CAR-T cell targeting receptor MR1 which promises ubiquitous T Cell cancer targeting for both solid and blood borne cancers! https://t.co/OsDne0wgcZ
RT @ja_majus: HUGE KUDOS and awaiting for the results from CTs!!!! "...a single type of T-cell that could be capable of destroying many dif…
RT @ja_majus: HUGE KUDOS and awaiting for the results from CTs!!!! "...a single type of T-cell that could be capable of destroying many dif…
RT @ja_majus: HUGE KUDOS and awaiting for the results from CTs!!!! "...a single type of T-cell that could be capable of destroying many dif…
HUGE KUDOS and awaiting for the results from CTs!!!! "...a single type of T-cell that could be capable of destroying many different types of cancers across the population. Previously nobody believed this could be possible.” https://t.co/z6DEVeI15F
RT @HeemstraLab: Exciting work from our collaborators in the Phillips and Sewell labs! MR1 allows T-cells to selectively recognize and kill…
Check out this brand new Nature article on a new CAR-T cell targeting receptor MR1 which promises ubiquitous T Cell cancer targeting for both solid and blood borne cancers! https://t.co/Fw8sEL1JkV
Check out this brand new Nature article on a new CAR-T cell targeting receptor MR1 which promises ubiquitous T Cell cancer targeting for both solid and blood borne cancers! https://t.co/MTFnfy6qS0
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 | Nature Immunology https://t.co/WI8BWXlldO
RT @toxiven_biotech: For further information go to link: https://t.co/RR06exxvIT
RT @immunoboys: Bonus +1: practical use of genome-wide CRISPR-Cas screen technology to identify unconventional T cell targets. Go and read…
@RealMsFeathers @thespybrief @gametheorytoday @LouiseMensch The team says human trials on terminally ill patients could begin as early as November if the new treatment passes further laboratory safety testing.” Free access to the research document via the
RT @RutterLab: Congrats to our friend and colleague John Phillips and his collaborators on their exciting new @NatImmunol paper! https://t.…
This is a big deal discovery in the world of cancer immunology: A T-cell receptor that specifically "hunts" cancer cells in a cancer-type-agnostic way. https://t.co/QLiXyfHwoz
Check out this brand new Nature article on a new CAR-T cell targeting receptor MR1 which promises ubiquitous T Cell cancer targeting for both solid and blood borne cancers! https://t.co/yejVGa4cEu
RT @HeemstraLab: Exciting work from our collaborators in the Phillips and Sewell labs! MR1 allows T-cells to selectively recognize and kill…